Physician profile
Talhat Azemi
NPI 1942407853
$12,050.74
in general payments reported to CMS, 2019-2025
24 companies · $1,596 in 2025
The $1,596 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,191 · 2020: $1,300 · 2021: $581 · 2022: $2,637 · 2023: $562 · 2024: $3,184 · 2025: $1,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,216 · Travel and Lodging: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,215.68 |
| Travel and Lodging | $1,125.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,493.87 | 2021-2025 | Corevalve Evolut R, Apollotm, Micra |
| Medtronic Vascular, INC. | $2,947.97 | 2019-2020 | |
| Abbott Laboratories | $2,143.28 | 2019-2025 | Absolute Pro, Mitraclip, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $1,067.71 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $295.45 | 2022 | |
| Bard Peripheral Vascular, INC. | $195.96 | 2021-2025 | Fluency Endovascular Stent Graft |
| Cardiovascular Systems INC. | $157.62 | 2020-2023 | Diamondback Coronary |
| Chiesi USA, INC. | $126.58 | 2019-2025 | Kengreal |
| Shockwave Medical, INC | $104.44 | 2025 | |
| Cook Medical LLC | $102.40 | 2019 | |
| Biotronik INC. | $56.93 | 2019-2022 | |
| Cardiva Medical, INC. | $51.91 | 2024 | Savvywire, Optowire |
| Astrazeneca Pharmaceuticals LP | $48.92 | 2020-2023 | Farxiga |
| Cordis US Corp. | $41.83 | 2022-2025 | Mynx Control Venous |
| Opsens INC. | $38.61 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $30.83 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.92 | 2019 | |
| Heartflow, INC. | $22.64 | 2022 | |
| Penumbra, INC. | $20.25 | 2023 | Indigo System |
| Terumo Medical Corporation | $18.25 | 2024 | Glidesheath Slender |
| Amgen INC. | $17.10 | 2022 | |
| Abiomed | $15.22 | 2020 | |
| Biomerieux INC | $15.02 | 2023 | |
| Siemens Medical Solutions USA, INC. | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Talhat Azemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.